SELL and breast cancer: Single cell studies in breast tumors, although quite recent, are starting to render fruits in the understanding of breast cancer heterogeneity as exemplified by the recent discovery of two lipid-associated macrophage states LAM1 and LAM2 (99) that are being established as biomarkers distinct clinical outcomes in several breast cancer datasets (100).